From May 21–23, we showcased our flagship solution, MSIcare, an AI-powered genomic analysis platform designed to detect microsatellite instability (MSI) from NGS data — a key biomarker for identifying patients likely to benefit from immunotherapy.
Our mission is to make precision oncology accessible by transforming complex genomic data into clinically actionable insights. At SantExpo, we look forward to connecting with healthcare professionals, researchers, and industry partners who share our vision of advancing personalized cancer care.
